Abstracts Archive - Page 298 of 1683 - ATC Abstracts

2021 American Transplant Congress
Response to a Pandemic: The Fall and Rise of Kidney Transplantation in the US
S. Bisen¹, B. Boyarsky¹, W. Werbel¹, J. Snyder², J. Garonzik-Wang¹, D. Segev¹, A. Massie¹
¹JHU, Baltimore, MD, ²SRTR, Minneapolis, MN
*Purpose: During the first wave of the COVID-19 epidemic in March-April 2020, waitlist registrations and living/deceased donor kidney transplants (LDKT/DDKT) dropped substantially. A second wave…
2021 American Transplant Congress
Non-Invasive Measurement of Transplant Kidney Fibrosis Using Photoacoustic Imaging
E. Hysi¹, X. He¹, A. Krizova¹, M. Ordon¹, K. T. Pace¹, M. Farcas¹, M. C. Kolios², D. A. Yuen¹
¹St. Michael's Hospital, Toronto, ON, Canada, ²Ryerson University, Toronto, ON, Canada
*Purpose: The presence of donor kidney fibrosis adversely impacts transplant outcome. Biopsy remains the only method that can assess fibrosis, despite being subjected to sampling…
2021 American Transplant Congress
Impact of Extended Living Donor Criteria on Donor Safety in Living Donor Liver Transplantation
J. KIM
Department of Surgery, Catholic University of Daegu College of Medicine, Daegu, Korea, Republic of
*Purpose: Donor safety is major concern during living donor liver transplantation (LDLT) and most transplant centers accept strict selection criteria although some centers have been…
2021 American Transplant Congress
Optimal Antimicrobial Duration for Donor Positive Cultures in Kidney Transplant Recipients
J. Ferrante, K. Schnelle, M. Palettas, S. Sarwar, H. Winters, M. Chunduru
Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Utilization of organs from infected donors carries the risk of transmission of the donor organism to the recipient. While antimicrobials are recommended in recipients…
2021 American Transplant Congress
Psychosocial Factors Influencing Patients’ Decision Making About Upper Extremity Vca
B. Kuramitsu¹, J. Gacki-Smith¹, A. Ferzola², K. Vanterpool², C. Kunkle³, M. Hewitt³, A. Schultheis³, T. Riggleman³, J. Taylor³, C. Cooney², M. Levan², S. Tintle³, G. Brandacher², E. Gordon¹
¹Northwestern University, Chicago, IL, ²Johns Hopkins University, Baltimore, MD, ³Walter Reed National Military Medical Center, Bethesda, MD
*Purpose: The informed consent process for upper extremity (UE) Vascularized Composite Allotransplantation (VCA) has yet to be standardized. Consequently, the information provided to patients about…
2021 American Transplant Congress
Growing LDLT Volumes at a US Center- What Does It Take to Do Over 100 LDLTs Per Year
A. Humar, C. Hughes, G. Mazariegos, K. Soltys, A. Gallatin, K. Emmett, A. Tevar, M. Molinari, A. Ganoza, V. Gunabushanam, S. Ganesh
University of Pittsburgh, Pittsburgh, PA
*Purpose: LDLT remains underutilized in the US, accounting for
2021 American Transplant Congress
Influence of Frailty on Psychometric Factors and Health-related Quality of Life in Patients on the Waitlist for Liver Transplantation
C. G. Klein, J. Latuske, E. Malamutmann, A. Paul, A. Oezcelik
University Medicine Essen, Essen, Germany
*Purpose: The aim of this prospective study was to evaluate the influence of frailty on depression, anxiety and health-related quality of life for patients on…
2021 American Transplant Congress
Basiliximab versus Alemtuzumab: The Association Between Induction Agent and Airway Complications Following Lung Transplantation
M. Furukawa¹, E. G. Chan¹, T. Harano¹, J. Ryan¹, R. Rivosecchi², M. R. Morrell¹, P. G. Sanchez¹
¹Cardiothoracic Surgery, UPMC, Pittsburgh, PA, ²PUH-Pharmacy, UPMC, Pittsburgh, PA
*Purpose: Controversy still exist regarding the best induction strategy for lung transplantation. At our institution, induction is defined based on donor recipient CMV match. While…
2021 American Transplant Congress
Pre Transplant Estimated Glomerular Filtration Rate and Other Predictors of Mortality and End Stage Kidney Disease After Lung Transplantation
A. Kumar¹, L. N. Bonnell², C. Thomas³
¹Internal Medicine, University of Vermont, Burlington, VT, ²Department of General Internal Medicine Research, University of Vermont, Burlington, VT, ³Internal Medicine, University of Iowa, Iowa City, IA
*Purpose: Lung transplantation is an established treatment for end stage lung disease and as survival has improved, chronic kidney disease (CKD) has become a common…
2021 American Transplant Congress
Mapping Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI) in Kidney Transplant Biopsies Reveals Two Classes of Early AKI That Differ in Their Response-to-Wounding
P. Halloran¹, J. Reeve¹, G. Böhmig², O. Viklicky³, M. Myslak⁴, G. Gupta⁵, &. the INTERCOMEX Study Group⁶
¹Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, ²Medical University of Vienna, Vienna, Austria, ³Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ⁴Pomeranian Medical University, Szczecin, Poland, ⁵Virginia Commonwealth University, Richmond, VA, ⁶., ., AB, Canada
*Purpose: We recently analyzed injury-induced molecular changes in kidney transplant biopsies using principal component analysis (PCA) (AJT https://doi.org/10.1111/ajt.16374). PC1 reflected all injury, PC2 distinguished early…